PHARMAGREEN BIOTECH INC. Interest and Debt Expense
PHARMAGREEN BIOTECH INC. reported Interest and Debt Expense of $8.22 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestAndDebtExpense · last filed 2023-08-14
- PHARMAGREEN BIOTECH INC. interest and debt expense for the quarter ending 2023-06-30 was $8.22K, a 23.58% decline year-over-year.
- PHARMAGREEN BIOTECH INC. interest and debt expense for the quarter ending 2023-03-31 was $8.13K, a 19.28% decline year-over-year.
- PHARMAGREEN BIOTECH INC. interest and debt expense for the quarter ending 2022-12-31 was $8.31K, a 17.64% decline year-over-year.
- PHARMAGREEN BIOTECH INC. interest and debt expense for the quarter ending 2022-09-30 was -$2.14K, a 128.18% decline year-over-year.
- PHARMAGREEN BIOTECH INC. interest and debt expense for fiscal 2022 was $28.78K, a 95.77% decline from fiscal 2021.
- PHARMAGREEN BIOTECH INC. interest and debt expense for fiscal 2021 was $680.71K, a 97.92% increase from fiscal 2020.
- PHARMAGREEN BIOTECH INC. interest and debt expense for fiscal 2020 was $343.94K.
| Period end | Interest and Debt Expense 3 month | Interest and Debt Expense 6 month | Interest and Debt Expense 9 month | Interest and Debt Expense 12 month |
|---|---|---|---|---|
| 2023-06-30 | $8.22K 10-Q · filed 2023-08-14 | $16.35K derived: sum of 2 quarters · filed 2023-08-14 | $24.66K 10-Q · filed 2023-08-14 | $22.52K derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | $8.13K 10-Q · filed 2023-05-19 | $16.44K 10-Q · filed 2023-05-19 | $14.30K derived: sum of 3 quarters · filed 2023-05-19 | $25.06K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-12-31 | $8.31K 10-Q · filed 2023-02-14 | $6.17K derived: sum of 2 quarters · filed 2023-02-14 | $16.93K derived: sum of 3 quarters · filed 2023-08-14 | $27.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-09-30 | -$2.14K derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-17 | $8.62K derived: sum of 2 quarters · filed 2023-08-14 | $18.69K derived: sum of 3 quarters · filed 2023-08-14 | $28.78K 10-K · filed 2023-01-17 |
| 2022-06-30 | $10.76K 10-Q · filed 2023-08-14 | $20.83K derived: sum of 2 quarters · filed 2023-08-14 | $30.92K 10-Q · filed 2023-08-14 | $38.51K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $10.07K 10-Q · filed 2023-05-19 | $20.16K 10-Q · filed 2023-05-19 | $27.75K derived: sum of 3 quarters · filed 2023-05-19 | $37.84K derived: sum of 4 quarters · filed 2023-05-19 |
| 2021-12-31 | $10.09K 10-Q · filed 2023-02-14 | $17.68K derived: sum of 2 quarters · filed 2023-02-14 | $27.77K derived: sum of 3 quarters · filed 2023-02-14 | $654.58K derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-09-30 | $7.59K derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-17 | $17.68K derived: sum of 2 quarters · filed 2023-01-17 | $644.48K derived: sum of 3 quarters · filed 2023-01-17 | $680.71K 10-K · filed 2023-01-17 |
| 2021-06-30 | $10.09K 10-Q · filed 2022-08-17 | $636.89K derived: sum of 2 quarters · filed 2022-08-17 | $673.12K 10-Q · filed 2022-08-17 | |
| 2021-03-31 | $626.81K 10-Q · filed 2022-05-16 | $663.04K 10-Q · filed 2022-05-16 | ||
| 2020-12-31 | $36.23K 10-Q · filed 2022-02-22 | |||
| 2020-09-30 | $343.94K 10-K · filed 2021-12-29 |